Tecnimede Group
Tecnimede Group is a Portuguese pharmaceutical company dedicated to research, development, production, and distribution of medicines. Founded in 1980, it focuses on addressing unfulfilled medical needs and improving human life through a comprehensive medication life cycle. The group has production centers in Portugal and Morocco, with a combined capacity of over 34 million units, and exports to more than 100 countries. Tecnimede is involved in various therapeutic areas including cardiology, oncology, and central nervous system, and has a portfolio of over 130 products. The company also engages in in-licensing, out-licensing, and release of products for the European area, with certified laboratories and extensive experience in batch release. It has a strong focus on innovation, with over 440 patents, and a broad portfolio including highly active products, vitamins, minerals, and various therapeutic classes. Tecnimede supports patient organizations and maintains active participation in industry associations. The company has received recognition as the Best and Largest Company in the healthcare sector in Portugal in 2023.
Industries
Nr. of Employees
large (251-1000)
Tecnimede Group
Products
Portfolio of generics and OTC medicines
A broad portfolio of generic and over-the-counter medicines across multiple therapeutic areas (cardiometabolic, anti-infectives, nervous system, respiratory, vitamins/minerals, corticosteroids, antineoplastics, etc.).
Portfolio of generics and OTC medicines
A broad portfolio of generic and over-the-counter medicines across multiple therapeutic areas (cardiometabolic, anti-infectives, nervous system, respiratory, vitamins/minerals, corticosteroids, antineoplastics, etc.).
Services
End-to-end manufacturing services for solid oral products including granulation, blending, compression, coating and capsule filling, with containment options for high-potency products.
Physico-chemical and microbiological testing for raw materials, packaging and finished products, plus stability testing and batch release support.
Validation of manufacturing and packaging processes, analytical methods, facility cleanliness and computerized systems supporting compliance activities.
Research and development across the full product lifecycle supporting new molecule development, formulation optimization and portfolio expansion.
Support for regulatory submissions, registration maintenance and marketing authorization management across international markets.
Services to support market entry, distribution and export, including direct presence in multiple countries and international partner networks.
End-to-end manufacturing services for solid oral products including granulation, blending, compression, coating and capsule filling, with containment options for high-potency products.
Physico-chemical and microbiological testing for raw materials, packaging and finished products, plus stability testing and batch release support.
Validation of manufacturing and packaging processes, analytical methods, facility cleanliness and computerized systems supporting compliance activities.
Research and development across the full product lifecycle supporting new molecule development, formulation optimization and portfolio expansion.
Support for regulatory submissions, registration maintenance and marketing authorization management across international markets.
Services to support market entry, distribution and export, including direct presence in multiple countries and international partner networks.
Expertise Areas
- Pharmaceutical manufacturing (solid, semi-solid, liquids and suspensions)
- High-potency/contained manufacturing for oncology products
- Quality control and analytical testing (release and stability)
- Quality assurance and method/computerized system validation
Key Technologies
- Wet/dry granulation and drying
- Powder blending
- Tableting / compression
- Film and functional coating for solid dosage forms
News & Updates
Tecnimede Group shared its experience in international markets, discussing strategies for internationalization and domestic profit generation.
Evaluation of Atlas Pharm, Tecnimede's production unit in Morocco dedicated to oncological treatments.
Showcasing its portfolio at the largest pharmaceutical event, reinforcing partnerships and exploring international opportunities.
Official launch event for the Tecnigen brand, discussing market trends and challenges for generics in Portugal and Europe.
Tecnimede was considered the top company in the healthcare sector according to Exame Portugal magazine.
Tecnimede Group shared its experience in international markets, discussing strategies for internationalization and domestic profit generation.
Evaluation of Atlas Pharm, Tecnimede's production unit in Morocco dedicated to oncological treatments.
Showcasing its portfolio at the largest pharmaceutical event, reinforcing partnerships and exploring international opportunities.
Official launch event for the Tecnigen brand, discussing market trends and challenges for generics in Portugal and Europe.
Tecnimede was considered the top company in the healthcare sector according to Exame Portugal magazine.